Enertopia (ENRT) S-1 26 Apr 21 IPO registration Financial data

Document and Entity Information

Document and Entity Information	6 Months Ended
	Feb. 28, 2021
Cover [Abstract]
Entity Registrant Name	Enertopia Corp.
Entity Central Index Key	0001346022
Entity Filer Category	Non-accelerated Filer
Document Type	S-1
Amendment Flag	false
Entity Small Business	true
Entity Emerging Growth Company	false

UNAUDITED CONDENSED INTERIM BAL

UNAUDITED CONDENSED INTERIM BALANCE SHEETS - USD ($)	Feb. 28, 2021	Aug. 31, 2020	Aug. 31, 2019
Current
Cash and cash equivalents	$ 416,246	$ 45,528	$ 9,758
Marketable securities	43,200	24,354
Accounts receivable	1,025	1,508	6,225
Prepaid expenses and deposit	53,754	14,824	30,262
Total current assets	514,225	86,214
Non-Current
Patents	69,000
Total Assets	583,225	86,214	46,245
Current
Accounts payable	274,510	290,336	283,430
Loan from related party			15,479
Due to related parties	159,959	188,834	203,221
Total Current Liabilities	434,469	479,170
Total Liabilities		479,170	502,130
STOCKHOLDERS' EQUITY
Share capital Authorized: 200,000,000 common shares with a par value of $0.001 per share Issued and outstanding: 136,231,700 common shares at February 28, 2021 and August 31,2020: 128,471,700 and August 31,2019: 127,471,700	494,346	128,473	127,473
Additional paid-in capital	14,007,059	13,758,598	13,730,801
Deficit	(14,352,649)	(14,280,027)	(14,314,159)
Total Stockholders' Equity	148,756	(392,956)	(455,885)
Total Liabilities and Stockholders' Equity	583,225	86,214	46,245
Commitments

UNAUDITED CONDENSED INTERIM B_2

UNAUDITED CONDENSED INTERIM BALANCE SHEETS (Parentheticals) - $ / shares	Feb. 28, 2021	Aug. 31, 2020	Aug. 31, 2019
Statement of Financial Position [Abstract]
Common stock, shares authorized	200,000,000	200,000,000	200,000,000
Common stock, par value per share	$ 0.001	$ 0.001	$ 0.001
Common stock, shares issued	136,231,700	128,471,700	127,471,700
Common stock, shares outstanding	136,231,700	128,471,700	127,471,700

CONDENSED INTERIM STATEMENTS OF

CONDENSED INTERIM STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)	COMMON STOCK [Member]	ADDITIONAL PAID-IN CAPITAL [Member]	DEFICIT ACCUMULATED [Member]	Total
Beginning Balance at Aug. 31, 2018	$ 119,741	$ 13,594,497	$ (13,891,818)	$ (177,580)
Beginning Balance (shares) at Aug. 31, 2018	119,739,931
Shares issued for Private Placement on September 21 (Shares)	2,225,000
Shares issued for Private Placement on September 21	$ 2,225	44,750		46,975
Shares issued for Private Placement on March 27 (shares)	5,506,769
Shares issued for Private Placement on March 27	$ 5,507	91,554		97,061
Comprehensive Income (loss)			(422,341)	(422,341)
Ending Balance at Aug. 31, 2019	$ 127,473	13,730,801	(14,314,159)	(455,885)
Ending Balance (shares) at Aug. 31, 2019	127,471,700
Shares issued for LOI on October 28 (shares)	1,000,000
Shares issued for LOI	$ 1,000	10,489		11,489
Comprehensive Income (loss)			(49,607)	(49,607)
Ending Balance at Nov. 30, 2019	$ 128,473	13,741,290	(14,363,766)	(494,003)
Ending Balance (shares) at Nov. 30, 2019	128,471,700
Beginning Balance at Aug. 31, 2019	$ 127,473	13,730,801	(14,314,159)	(455,885)
Beginning Balance (shares) at Aug. 31, 2019	127,471,700
Shares issued for LOI on October 28 (shares)	1,000,000
Shares issued for LOI	$ 1,000	10,489		11,489
Share based compensation		17,308		17,308
Comprehensive Income (loss)			34,132	34,132
Ending Balance at Aug. 31, 2020	$ 128,473	13,758,598	(14,280,027)	(392,956)
Ending Balance (shares) at Aug. 31, 2020	128,471,700
Beginning Balance at Nov. 30, 2019	$ 128,473	13,741,290	(14,363,766)	(494,003)
Beginning Balance (shares) at Nov. 30, 2019	128,471,700
Stock options granted		17,308		17,308
Comprehensive Income (loss)			145,785	145,785
Ending Balance at Feb. 29, 2020	$ 128,473	13,758,598	(14,217,981)	(330,910)
Ending Balance (shares) at Feb. 29, 2020	128,471,700
Comprehensive Income (loss)			(30,797)	(30,797)
Ending Balance at May. 31, 2020	$ 128,473	13,758,598	(14,248,778)	(361,707)
Ending Balance (shares) at May. 31, 2020	128,471,700
Comprehensive Income (loss)			(31,249)	(31,249)
Ending Balance at Aug. 31, 2020	$ 128,473	13,758,598	(14,280,027)	(392,956)
Ending Balance (shares) at Aug. 31, 2020	128,471,700
Stock options granted		15,450		15,450
Comprehensive Income (loss)			222,603	222,603
Ending Balance at Nov. 30, 2020	$ 128,473	13,774,048	(14,057,424)	(154,903)
Ending Balance (shares) at Nov. 30, 2020	128,471,700
Beginning Balance at Aug. 31, 2020	$ 128,473	13,758,598	(14,280,027)	$ (392,956)
Beginning Balance (shares) at Aug. 31, 2020	128,471,700
Stock options exercised (shares)				2,720,000
Warrants exercised (shares)				40,000
Ending Balance at Feb. 28, 2021	$ 494,346	14,007,059	(14,352,649)	$ 148,756
Ending Balance (shares) at Feb. 28, 2021	136,231,700
Beginning Balance at Nov. 30, 2020	$ 128,473	13,774,048	(14,057,424)	(154,903)
Beginning Balance (shares) at Nov. 30, 2020	128,471,700
Shares issued for patent (Shares)	2,000,000
Shares issued for patent	$ 69,000			69,000
Private placement (shares)	3,000,000
Private placement	$ 159,009	20,991		180,000
Stock options granted		273,236		$ 273,236
Stock options exercised (shares)	2,720,000			2,720,000
Stock options exercised	$ 135,609	(60,561)		$ 75,048
Warrants exercised (shares)	40,000
Warrants exercised	$ 2,256	(656)		1,600
Comprehensive Income (loss)			(295,225)	(295,225)
Ending Balance at Feb. 28, 2021	$ 494,346	$ 14,007,059	$ (14,352,649)	$ 148,756
Ending Balance (shares) at Feb. 28, 2021	136,231,700

CONDENSED INTERIM STATEMENTS _2

CONDENSED INTERIM STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Feb. 28, 2021	Feb. 29, 2020	Feb. 28, 2021	Feb. 29, 2020	Aug. 31, 2020	Aug. 31, 2019
Expenses
Accounting and audit	$ 11,026	$ 15,476	$ 16,261	$ 21,825	$ 48,314	$ 54,196
Bank charges and interest expense	329	517	554	1,062	1,651	1,192
Consulting	10,500		13,500	10,500	26,822	49,873
Mineral exploration costs	3,540	1,047	4,913	13,625	16,732	122,423
Fees and dues	7,122	10,029	13,938	15,739	19,851	34,858
Insurance				3,605	3,605	12,031
Investor relations	11,427	5,754	15,674	11,489	22,510	101,668
Legal and professional	7,252	5,020	11,165	7,410	8,688	7,175
Office and miscellaneous	289	9	1,297	136	990	4,016
Research and development	1,349		3,333	494	1,702	14,729
Rent	1,722	489	1,722	1,963	1,963	6,627
Stock-based compensation	273,236	17,308	288,686	17,308	17,308
Travel						10,173
Total expenses	327,792	55,649	371,043	105,156	170,136	418,961
Loss for the period before other items	(327,792)	(55,649)	(371,043)	(105,156)	(170,136)	(418,961)
Other income (expense)
Foreign exchange gain (loss)	(1,040)	1,434	(2,330)	1,334	1,067	(3,380)
Unrealized gain on marketable securities	11,997		28,247		3,201
Gain on disposal of marketable securities	21,610		22,504
Income from royalty grant		200,000	250,000	200,000	200,000
Net Income (loss) and comprehensive Income (loss) for the period	$ (295,225)	$ 145,785	$ (72,622)	$ 96,178	$ 34,132	$ (422,341)
Basic earnings (loss) per share (in dollars per share)	$ 0	$ 0	$ 0	$ 0
Diluted earnings (loss) per share (in dollars per share)	$ 0	$ 0	$ 0	$ 0
Basic and diluted income (loss) per share (in dollars per share)					$ 0	$ 0
Weighted average number of common shares outstanding - basic (in shares)	132,405,922	128,471,700	130,427,943	128,153,019
Weighted average number of common shares outstanding - diluted (in shares)	132,405,922	128,471,700	130,427,943	128,153,019
Weighted average number of common shares outstanding - basic and diluted (in shares)					128,313,230	124,205,582

CONDENSED INTERIM STATEMENTS _3

CONDENSED INTERIM STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended		12 Months Ended
	Feb. 28, 2021	Feb. 29, 2020	Aug. 31, 2020	Aug. 31, 2019
Cash flows used in operating activities
Net Income (loss)	$ (72,622)	$ 96,178	$ 34,132	$ (422,341)
Changes to reconcile net loss to net cash used in operating activities
Shares issued for exploration cost		11,489	11,489
Stock-based compensation	288,686	17,308	17,308
Income from Royalty grant	(250,000)	(200,000)	(200,000)
Unrealized gain on marketable securities	(28,247)		(3,201)
Gain on disposal of marketable securities	(22,504)
Interest on loan payable		699	699	178
Change in non-cash working capital items:
Accounts receivable	483	5,626	4,717	1,279
Prepaid expenses and deposit	(38,930)	11,474	15,438	57,515
Accounts payable and accrued liabilities	(15,826)	(6,656)	6,696	5,394
Due to related parties	(28,875)	2,169	(14,387)	31,987
Net cash (used in) operating activities	(167,835)	(61,713)	(127,109)	(325,988)
Cash flows from Investing activities
Purchase of marketable securities			(21,153)
Proceeds from disposal of marketable securities	31,905
Proceeds from royalty grant	250,000	200,000	200,000
Net cash from investing activities	281,905	200,000	178,847
Cash flows from (used in) Financing activities
Proceeds from loan from related party				15,301
Net proceeds from options exercised	75,048
Net proceeds from warrants exercised	1,600
Net proceeds from subscriptions received	180,000			144,036
Repayment of loan from related party		(15,968)	(15,968)
Net cash from (used in) Financing activities	256,648	(15,968)	(15,968)	159,337
Increase (Decrease) in cash and cash equivalents	370,718	122,319	35,770	(166,651)
Cash and cash equivalents, beginning of period	45,528	9,758	9,758	176,409
Cash and cash equivalents, end of period	416,246	132,077	45,528	$ 9,758
Supplemental information of cash flows
Interest paid in cash	0	699	$ 666
Income taxes paid in cash	$ 0	$ 0

ORGANIZATION

ORGANIZATION	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION [Text Block]	1. ORGANIZATION The unaudited condensed interim financial statements for the period ended February 28, 2021 included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with United States generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. These unaudited condensed interim financial statements should be read in conjunction with the August 31, 2020 audited annual financial statements and notes thereto. The Company was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. The Company was an independent natural resource company engaged in the exploration, development and acquisition of natural resources in the United States and Canada. In the fiscal year 2010, the Company shifted its strategic plan from its non-renewal energy operations to its planned renewal energy operations and natural resource acquisition and development. In late summer of 2013, the Company had another business sector in alternative health and wellness. During spring of 2016, the Company shifted its strategic plan to natural resource acquisitions and Lithium brine extraction technology. The Company office is located in Kelowna, B.C., Canada.	1. ORGANIZATION The Company was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. The Company was an independent natural resource company engaged in the exploration, development and acquisition of natural resources in the United States and Canada. In the fiscal year 2010, the Company shifted its strategic plan from its non-renewable energy operations to its planned renewable energy operations and natural resource acquisition and development. In late summer of 2013, the Company had another business sector in alternative health and wellness. During spring of 2016, the Company shifted its strategic plan to natural resource acquisitions and Lithium brine extraction technology. The Company's office is located in Kelowna, B.C., Canada.

GOING CONCERN UNCERTAINTY

GOING CONCERN UNCERTAINTY	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020
Going Concern Uncertainty [Abstract]
GOING CONCERN UNCERTAINTY [Text Block]	2. GOING CONCERN UNCERTAINTY The accompanying unaudited condensed interim financial statements have been prepared on a going concern basis which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business for the foreseeable future. The Company incurred net cash outflows from operating activities of $167,835 for the six months ended February 28, 2021 ($61,713 for the six months ended February 29, 2020) and as at February 28, 2021 has incurred cumulative losses of $14,352,649 that raises substantial doubt about its ability to continue as a going concern. Management has been able, thus far, to finance the operations through equity financing and cash on hand. There is no assurance that the Company will be able to continue to finance the Company on this basis. In view of these conditions, the ability of the Company to continue as a going concern is in substantial doubt and dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to obtain additional financing as may be required, to receive the continued support of the Company's shareholders, and ultimately to obtain successful operations. There are no assurances that we will be able to obtain further funds required for our continued operations. As noted herein, we are pursuing various financing alternatives to meet our immediate and long-term financial requirements. There can be no assurance that additional financing will be available to us when needed or, if available, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will be unable to conduct our operations as planned, and we will not be able to meet our other obligations as they become due. In such event, we will be forced to scale down or perhaps even cease our operations. There is significant uncertainty as to whether we can obtain additional financing. These unaudited condensed interim financial statements do not give effect to any adjustments which would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying unaudited condensed interim financial statements. Since March 2020, several measures have been implemented in Canada, the United States, and the rest of the world in response to the increased impact from the novel coronavirus ("COVID-19"). While the impact of COVID-19 is expected to be temporary, the current circumstances are dynamic and the impact on our business operations cannot be reasonably estimated at this time. We anticipate this could have an adverse impact on our exploration plans, results of operations, financial position and cash flows.	2. GOING CONCERN UNCERTAINTY The accompanying financial statements have been prepared on a going concern basis which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business for the foreseeable future. The Company had a working capital deficit of $392,956 as at August 31, 2020 (2019 - $455,885). As at August 31, 2020 the Company has incurred cumulative losses of $14,280,027 that raises substantial doubt about its ability to continue as a going concern. Management has been able, thus far, to finance the operations through equity financing and cash on hand. There is no assurance that the Company will be able to continue to finance the Company on this basis. In view of these conditions, the ability of the Company to continue as a going concern is in substantial doubt and dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to obtain additional financing as may be required, to receive the continued support of the Company's shareholders, and ultimately to obtain successful operations. There are no assurances that we will be able to obtain further funds required for our continued operations. As noted herein, we are pursuing various financing alternatives to meet our immediate and long-term financial requirements. There can be no assurance that additional financing will be available to us when needed or, if available, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will be unable to conduct our operations as planned, and we will not be able to meet our other obligations as they become due. In such event, we will be forced to scale down or perhaps even cease our operations. There is significant uncertainty as to whether we can obtain additional financing. These financial statements do not give effect to any adjustments which would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying financial statements. Since March 2020, several measures have been implemented in Canada, the United States, and the rest of the world in response to the increased impact from the novel coronavirus ("COVID-19"). While the impact of COVID-19 is expected to be temporary, the current circumstances are dynamic and the impact on our business operations cannot be reasonably estimated at this time. We anticipate this could have an adverse impact on our exploration plans, results of operations, financial position and cash flows.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES [Text Block]	3. SIGNIFICANT ACCOUNTING POLICIES a) Basis of Presentation The accompanying unaudited condensed interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and the instructions to Securities and Exchange Commission ("SEC") Form 10-Q and Article 10 of SEC Regulation S-X. They do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. Therefore, these financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended August 31, 2020. b) Accounting Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. On an ongoing basis, we evaluate our estimates, judgments, and assumptions, including those related to stock based compensation (expense and liability). Our estimates, judgments, and assumptions are based on historical experience, future expectations, and other factors which we believe to be reasonable. Actual results could differ from those estimates and assumptions.	3. SIGNIFICANT ACCOUNTING POLICIES a. Basis of Presentation The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles. b. Mineral Properties Acquisition costs of mineral rights are initially capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time proven or probable reserves are established for that project. Acquisition costs include cash consideration and the fair market value of shares issued on the acquisition of mineral properties. Expenditures relating to exploration activities are expensed as incurred and expenditures relating to pre-extraction activities are expensed as incurred until such time proven or probable reserves are established for that project, after which subsequent expenditures relating to development activities for that particular project are capitalized as incurred. Where proven and probable reserves have been established, the project's capitalized expenditures are depleted over proven and probable reserves using the units-of production method upon commencement of production. Where proven and probable reserves have not been established, the project's capitalized expenditures are depleted over the estimated extraction life using the straight-line method upon commencement of extraction. The Company has not established proven or probable reserves for any of its projects. The carrying values of the mineral rights are assessed for impairment by management on a quarterly basis and as required whenever indicators of impairment exist. An impairment loss is recognized if it is determined that the carrying value is not recoverable and exceeds fair value. c. Stock-Based Compensation The Company followed Accounting Standards Codification ("ASC") 718, "Compensation - Stock Compensation", to account for its stock options and similar equity instruments issued. Accordingly, compensation costs attributable to stock options or similar equity instruments granted are measured at the fair value at the grant date, and expensed over the expected vesting period. ASC 718 requires excess tax benefits be reported as a financing cash inflow rather than as a reduction of taxes paid. d. Accounting Estimates The preparation of financial statements in conformity with U.S GAAP requires us to make certain estimates, judgements and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Some of the Company's accounting policies require us to make subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. These accounting policies involve critical accounting estimates because they are particularly dependent on estimates and assumptions made by management about matters that are highly uncertain at the time the accounting estimates are made. Although we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have been used. Changes in the accounting estimates used by the Company are reasonably likely to occur from time to time, which may have a material effect on the presentation of financial condition and results of operations. The Company reviews these estimates, judgments and assumptions periodically and reflect the effects of revisions in the period in which they are deemed to be necessary. We believe that these estimates are reasonable; however, actual results could differ from these estimates. Significant accounting estimates and assumptions are used for, but not limited to: a) Judgement is required in determining whether deferred tax assets are recognized on the balance sheet. The recognition of deferred tax assets requires management to assess the likelihood that the Company will generate taxable income in future periods to utilize the deferred tax assets. Due to the Company's history of losses, deferred tax assets have not been recognized by the Company. b) The Company provides compensation benefits to its employees, directors, officers, and consultants, through a stock option plan. The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model. Expected volatility assumption used in the model is based on the historical volatility of the Company's share price. The Company uses historical data to estimate the period of option exercises for use in the valuation model. The risk-free interest rate for the expected term of the option is based on the yields of government bonds. Changes in these assumptions, especially the share price volatility and the expected life determination could have a material impact on the Company's profit and loss for the periods presented. All estimates used in the model are based on historical data which may not be representative of future results. e. Earnings Per Share Loss per share is computed using the weighted average number of shares outstanding during the period. The Company has adopted ASC 220 "Earnings Per Share". Diluted loss per share is equivalent to basic loss per share because the potential exercise of the equity-based financial instruments was anti-dilutive. Basic earnings per share ("EPS") is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method. Dilutive potential common shares include outstanding stock options and stock awards. f. Foreign Currency Translations The Company's operations are located in the United States of America and has its office in Canada. The Company maintains its accounting records in U.S. Dollars, as follows: At the transaction date, each asset, liability, revenue and expense that was acquired or incurred in a foreign currency is translated into U.S. dollars by the using of the exchange rate in effect at that date. At the year end, monetary assets and liabilities are translated at the exchange rate in effect at that date. The resulting foreign exchange gains and losses are included in operations. g. Financial Instruments ASC 820 "Fair Value Measurements and Disclosures" requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 - Quoted prices in active markets for identical assets or liabilities; Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing. The Company's financial instruments consist primarily of cash, marketable securities, accounts receivable, accounts payable, loan from related party and due to related parties. The carrying amounts of these financial instruments approximate their fair values due to their short maturities. Cash and marketable securities are in level 1 within the fair value hierarchy. The Company's operations are in United States of America and Canada, which results in exposure to market risks from changes in foreign currency rates. The financial risk is the risk to the Company's operations that arise from fluctuations in foreign exchange rates and the degree of volatility of these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. h. Income Taxes The Company has adopted ASC 740, "Income Taxes", which requires the Company to recognize deferred tax liabilities and assets for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns using the liability method. Under this method, deferred tax liabilities and assets are determined based on the temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the year in which the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized. i. Long-Lived Assets Impairment In accordance with ASC 360, "Accounting for Impairment or Disposal of Long Lived Assets", the carrying value of long lived assets are tested for recoverability whenever events or changes in circumstances indicate that its carrying amount may not be recoverable. The Company recognizes impairment when the sum of the expected undiscounted future cash flows is less than the carrying amount of the asset. Impairment losses, if any, are measured as the excess of the carrying amount of the asset over its estimated fair value. j. Asset Retirement Obligations The Company accounts for asset retirement obligations in accordance with the provisions of ASC 410, "Asset Retirement and Environmental Obligations". ASC 410 requires the Company to record the fair value of an asset retirement obligation as a liability in the period in which it incurs a legal obligation associated with the retirement of tangible long-lived assets that result from the acquisition, construction, development and/or normal use of the assets. The Company does not believe it has any asset retirement obligation as of August 31, 2020 and 2019. k. Comprehensive Income The Company has adopted ASC 220, "Comprehensive Income", which establishes standards for reporting and display of comprehensive income, its components and accumulated balances. The Company is disclosing this information on its Statement of Stockholders' Deficiency. Comprehensive income comprises equity except those transactions resulting from investments by owners and distributions to owners. l. Concentration of credit risk The Company places its cash with high credit quality financial institution. m. Commitments and Contingencies In accordance with ASC 450-20, Accounting for Contingencies, the Company records accruals for such loss contingencies when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. In the event that estimates or assumptions prove to differ from actual results, adjustments are made in subsequent periods to reflect more current information. Historically, the Company has not experienced any material claims. n. Research and Development Research and development costs are expensed as incurred. o. Recently adopted Accounting Pronouncements In June 2018, the FASB issued ASU 2018-07, which simplifies the accounting for nonemployee share-based payment transactions. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor's own operations by issuing share-based payment awards. The adoption of this ASU did not have any impact on these financial statements. In February 2016, Topic 842, Leases was issued to replace the leases requirements in Topic 840, Leases. The main difference between previous GAAP and Topic 842 is the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. A lessee should recognize in the balance sheet a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. The adoption of this standard did not have any impact on the Company's results of operations, financial condition, cash flows, and financial statement disclosures, as the Company's leases are all for terms of less than 12 months. p. New Accounting Pronouncements In June 2016, the FASB issued a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The standard will be adopted upon the effective date for us beginning September 1, 2020. The adoption of the standard is not expected to have a significant impact on the Company's financial statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements to Fair Value Measurement. For all entities, amendments are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. Early adoption is permitted. An entity is permitted to early adopt any removed or modified disclosures upon issuance of ASU No. 2018-13 and delay adoption of the additional disclosures until their effective date. We do not expect that the adoption of this ASU will have a significant impact on our financial statements. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company's financial statements upon adoption.

MARKETABLE SECURITIES

MARKETABLE SECURITIES	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020
Investments, Debt and Equity Securities [Abstract]
MARKETABLE SECURITIES [Text Block]	4. MARKETABLE SECURITIES Marketable securities consist of the Company's investment in units of Grayscale Bitcoin Trust. As at February 28, 2021, the movement in the Company's marketable securities is as follows: Balance, August 31, 2019 — Additions - cost 21,153 Unrealized gain 3,201 Balance, August 31, 2020 24,354 Proceeds from disposals (31,905 ) Gain on disposals 22,504 Unrealized gain 28,247 Balance, February 28, 2021 43,200	4. MARKETABLE SECURITIES Marketable securities consists of the Company's investment in units of Grayscale Bitcoin Trust acquired for net cost of $21,153. As at August 31, 2020, the movement in the Company's marketable securities is as follows: Balance, August 31, 2019 — Additions - cost 21,153 Unrealized gain 3,201 Balance, August 31, 2020 24,354

MINERAL PROPERTY

MINERAL PROPERTY	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020
Mineral Industries Disclosures [Abstract]
MINERAL PROPERTY [Text Block]	5. MINERAL PROPERTY During the year ended August 30, 2017 the Company staked lode and placer claims on BLM lands in Esmerelda county Nevada covering approximately 160 Acres subject to adjustment. The Company has a 100% interest in the lands and is only responsible for the yearly maintenance fees to keep its 100% interest. The claims are in good standing until August 31, 2021. On October 28, 2019, the Company signed an LOI with Eagle Plains Resources Ltd. ("Eagle Plains") to earn up to 75% interest in the Pine Channel gold project in Saskatchewan, Canada (the "Pine Channel SK Property"). The terms of the LOI included periodic payments cash payments, exploration expenditures, as well as issuance of common shares of the Company. Upon signing the LOI, the Company issued 1,000,000 of its common shares to Eagle Plains, valued at $11,489. The Company dropped the LOI on Dec 13th, 2019 and has no further related commitments. On February 11, 2020, the Company signed a 1% Royalty agreement with respect to any future commercial lithium production from the Company's Clayton Valley, Nevada claims in exchange for $200,000. The Company has a right of first refusal to repurchase the royalty upon any proposed sale by the royalty holder to a third party. On October 29, 2020, the Company signed a 1% Royalty agreement with respect to any future commercial lithium production from the Company's Clayton Valley, Nevada claims in exchange for $250,000. The Company has a right of first refusal to repurchase the royalty upon any proposed sale by the royalty holder to a third party.	5. MINERAL PROPERTY During the year ended August 30, 2017 the Company staked lode and placer claims on BLM lands in Esmerelda county Nevada covering approximately 160 Acres subject to adjustment. The Company has a 100% interest in the lands and is only responsible for the yearly maintenance fees to keep its 100% interest. The claims are in good standing until August 31, 2021. On October 28, 2019, the Company signed an LOI with Eagle Plains Resources Ltd. ("Eagle Plains") to earn up to 75% interest in the Pine Channel gold project in Saskatchewan, Canada (the "Pine Channel SK Property"). The terms of the LOI included periodic payments cash payments, exploration expenditures, as well as issuance of common shares of the Company. Upon signing the LOI, the Company issued 1,000,000 of its common shares to Eagle Plains, valued at $11,489. On December 13 th On February 11, 2020 the Company signed a 1% Royalty agreement with respect to any future commercial lithium production from the Company's Clayton Valley, Nevada claims in exchange for $200,000. The Company has a right of first refusal to repurchase the royalty upon any proposed sale by the royalty holder to a third party.

PATENTS

PATENTS	6 Months Ended
	Feb. 28, 2021
Patents [Abstract]
PATENTS [Text Block]	6. PATENTS On December 14, 2020 the Company signed Definitive Agreement to acquire 100% interest in United States Patent and Trademark Office ("USPTO") patent #6,024,086

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS [Text Block]	7. RELATED PARTIES TRANSACTION For the six month period ended , the Company was party to the following related party transactions: The Company incurred $ Nil During the six months ended February 28, 2021, the Company repaid $28,875 of amounts outstanding resulting in accounts payable to the President of the Company of $159,959 as at February 28, 2021 (August 31, 2020: $188,834). On December 14, 2020 the Company issued 500,000 stock options valued at $10,917 to the President of the Company (Note 9). The related party transactions are recorded at the exchange amount established and agreed to between the related parties.	6. RELATED PARTY TRANSACTIONS For the year ended August 31, 2020, the Company was party to the following related party transactions with key management personnel, which consists of the President and Chief Executive Officer of the Company and its directors: Incurred $10,500 (2019 - $42,000) to the President of the Company in consulting fees (Note 8). As at August 31, 2019, the accounts payable to the President of the Company was $188,834 (2019: $203,221) Repaid a short-term loan from the President of the Company in the amount of CAD$21,156 including accrued interest ($15,968). Incurred $Nil (2019: $395) to a director of the Company. The related party transactions are recorded at the exchange amount established and agreed to between the related parties.

COMMON STOCK

COMMON STOCK	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020
Stockholders' Equity Note [Abstract]
COMMON STOCK [Text Block]	8. COMMON STOCK On October 28, 2019 the Company issued 1,000,000 shares to Eagle Plains Resources Ltd. upon entering LOI (Note 5). On December 14, 2020 the Company issued 1,000,000 common shares and an additional 1,000,000 common shares in escrow in connection with the signed Definitive Agreement (Note 6). On January 14, 2021 the Company closed the final tranche of a private placement of 3,000,000 units at a price of $0.06 per unit for gross proceeds of $180,000. Each unit consists of one common share of the Company and one half (0.5) of a non-transferable share purchase warrant, each warrant entitling the holder to purchase one additional common share of the Company for a period of 12 months from the date of issuance at a purchase price of $0.09. During the six months ended February 28, 2021 the Company also issued 2,720,000 common shares as a result of the exercise of stock options and 40,000 common shares as a result of the exercise of warrants (Note 9). As at February 28, 2021 and August 31, 2020 the Company had 136,231,700 (August 31, 2020: 128,471,700) shares issued and outstanding.	7. COMMON STOCK On September 21, 2018, the Company closed a tranche of a private placement of 2,225,000 units at a price of CAD$0.03 per unit for gross proceeds of CAD$66,750 (equivalent to $51,678). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 36 months from the date of issuance, at a purchase price of $0.05. A cash finders' fee of CAD$6,075 ($4,703) and 202,500 full broker warrants that expire September 21, 2021 was paid to third parties. The broker warrants have the same terms as the warrants issued as part of the unit offering. On March 27, 2019, the Company closed a tranche of a private placement of 5,506,769 units at a price of CAD$0.03 per unit for gross proceeds of CAD$143,176 ($106,809). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 48 months from the date of issuance, at a purchase price of $0.04. A cash finders' fee of CAD$13,068 ($9,748) and 502,600 full broker warrants that expire March 27, 2023 was paid to third parties. The broker warrants have the same terms as the warrants issued as part of the unit offering. On October 28, 2019 the Company issued 1,000,000 shares to Eagle Plains Resources Ltd upon entering LOI (Note 4). As at August 31, 2020 the Company had 128,471,700 shares issued and outstanding (2019 - 127,471,700).

STOCK OPTIONS AND WARRANTS

STOCK OPTIONS AND WARRANTS	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020
Share-based Payment Arrangement [Abstract]
STOCK OPTIONS AND WARRANTS [Text Block]	9. STOCK OPTIONS AND WARRANTS Stock Options On July 15, 2014, the shareholders approved and adopted at the Annual General Meeting the Company's 2014 Stock Option Plan. On April 14, 2011, the shareholders approved and adopted at the Annual General Meeting to consolidate the Company's 2007 Equity compensation plan and the Company's 2010 Equity Compensation Plan into a new Company 2011 Stock Option Plan. The purpose of these Plans is to advance the interests of the Corporation, through the grant of Options, by providing an incentive mechanism to foster the interest of eligible persons in the success of the Corporation and its affiliates; encouraging eligible persons to remain with the Corporation or its affiliates; and attracting new Directors, Officers, Employees and Consultants. On November 12, 2020, the Company issued 500,000 stock options to one of the consultants of the Company with an exercise price of $0.05 vested immediately, expiring November 12, 2025. On December 14, 2020, the Company issued 2,100,000 stock options to consultants and officers of the Company with an exercise price of $0.05 vested immediately, expiring December 14, 2025. On January 28, 2021, the Company issued 2,000,000 stock options to one of the consultants of the Company with an exercise price of $0.14 vested immediately, expiring January 28, 2026. On February 4, 2021, the Company issued 100,000 stock options to one of the consultants of the Company with an exercise price of $0.18 vested immediately, expiring February 4, 2026. On February 5, 2021, the Company issued 300,000 stock options to three of the consultants of the Company with an exercise price of $0.18 vested immediately, expiring February 5, 2026. The fair value of the options granted was estimated on the date of the grant using the Black-Scholes options pricing model, with the following weighted average assumptions: Expected dividend yield 0.00% Expected stock volatility 98% Risk-free interest rate 0.40% Expected life of options (years) 5.00 Expected forfeiture rate 0.00% Grant date fair value per option $0.06 During the six month period ended February 28, 2021, the Company recorded $288,686 (February 29, 2020 - $17,308) as stock based compensation expenses. In addition, the Company issued 2,720,000 (February 29, 2020: Nil) common shares of the Company as a result of exercised stock options for gross proceeds of $75,048 and a total of 1,100,000 stock options expired without being exercised (February 29, 2020: 1,000,000). A summary of the changes in stock options for the six months ended February 28, 2021 is presented below: Options Outstanding Weighted Average Number of Shares Exercise Price Balance, August 31, 2019 8,320,000 $ 0.07 Issued 2,000,000 0.02 Expired (1,000,000 ) 0.10 Balance, August 31, 2020 9,320,000 $ 0.06 Issued 5,000,000 0.10 Expired (1,100,000 ) 0.05 Exercised (2,993,224 ) 0.04 Balance, February 28, 2021 10,226,776 $ 0.08 The Company has the following options outstanding and exercisable: February 28, 2021 Issue Date Expiry Date Exercise Price Number of Options Remaining Life September 19, 2016 September 19, 2021 0.07 700,000* 0.56 years January 20, 2017 January 20, 2022 0.07 1,200,000* 0.89 years January 31, 2017 January 31, 2022 0.07 1,250,000* 0.92 years May 2, 2017 May 2, 2022 0.10 500,000* 1.17 years October 27, 2017 October 27, 2022 0.05 800,000* 1.66 years May 11, 2018 May 11, 2023 0.06 500,000* 2.20 years May 22, 2018 May 22, 2023 0.07 550,000* 2.23 years February 25, 2020 February 25, 2022 0.02 226,776* 0.99 years December 14, 2020 December 14, 2025 0.05 2,100,000* 4.79 years January 28, 2021 January 28, 2026 0.14 2,000,000* 4.92 years February 4, 2021 February 4, 2026 0.18 100,000 4.94 years February 5, 2021 February 5, 2026 0.18 300,000 4.94 years 0.08 10,226,776 2.52 years *As at February 28, 2021 the market price of the Company's common shares was $0.1426 per share. A total of 9,826,776 incentive stock options were in the money with an intrinsic value of $882,363. August 31, 2020 Issue Date Expiry Date Exercise Price Number of Options Remaining Life October 23, 2015 October 23, 2020 0.05 1,100,000 0.15 years September 19, 2016 September 19, 2021 0.07 800,000 1.05 years January 20, 2017 January 20, 2022 0.07 1,535,000 1.39 years January 31, 2017 January 31, 2022 0.07 1,500,000 1.42 years May 2, 2017 May 2, 2022 0.10 500,000 1.67 years October 27, 2017 October 27, 2022 0.05 800,000 2.16 years May 11, 2018 May 11, 2023 0.06 535,000 2.70 years May 22, 2018 May 22, 2023 0.07 550,000 2.73 years February 25, 2020 February 25, 2022 0.02 2,000,000 1.49 years 0.06 9,320,000 1.48 years Warrants During the period ended February 28, 2021 the Company issued 1,500,000 warrants attached to units in a private placement, see Note 8. A summary of warrants as at February 28, 2021 and August 31, 2020 is as follows: Weighted Average Number of warrants Exercise Price Balance, August 31, 2019 26,141,459 $ 0.06 Expired (12,904,590 ) 0.07 Balance, August 31, 2020 13,236,869 $ 0.06 Issued 1,500,000 0.09 Exercised (40,000 ) 0.04 Balance, February 28, 2021 14,696,869 $ 0.05 The Company has the following warrants outstanding: February 28, 2021 Issue Date Expiry Date Exercise Price Number of Warrants* August 31, 2018 August 31, 2021 0.05 4,800,000 September 21, 2018 September 21, 2021 0.05 2,427,500 March 27, 2019 March 27, 2023 0.04 5,969,369 January 14, 2021 January 14, 2022 0.09 1,500,000 0.05 14,696,869 *Each warrant entitles a holder to purchase one common share. August 31, 2020 Issue Date Expiry Date Exercise Price Number of Warrants* August 31, 2018 August 31, 2021 0.05 4,800,000 September 21, 2018 September 21, 2021 0.05 2,427,500 March 27, 2019 March 27, 2023 0.04 6,009,369 0.05 13,236,869	8. STOCK OPTIONS AND WARRANTS Stock Options On July 15, 2014, the shareholders approved and adopted at the Annual General Meeting the Company's 2014 Stock Option Plan. On April 14, 2011, the shareholders approved and adopted at the Annual General Meeting to consolidate the Company's 2007 Equity compensation plan and the Company's 2010 Equity Compensation Plan into a new Company 2011 Stock Option Plan. The purpose of these Plans is to advance the interests of the Corporation, through the grant of Options, by providing an incentive mechanism to foster the interest of eligible persons in the success of the Corporation and its affiliates; encouraging eligible persons to remain with the Corporation or its affiliates; and attracting new Directors, Officers, Employees and Consultants. On February 25, 2020 the Company granted 2,000,000 stock options to a consultant of the Company with an exercise price of $0.02, expiring February 25, 2022. For the year ended August 31, 2020, the Company recorded $17,308 (2019 - $ Nil A summary of the changes in stock options is presented below: Options Outstanding Weighted Average Number of Shares Exercise Price Balance, August 31, 2018 8,570,000 $ 0.07 Expired (250,000 ) 0.06 Balance, August 31, 2019 8,320,000 $ 0.07 Granted 2,000,000 0.02 Expired (1,000,000 ) 0.10 Balance, August 31, 2020 9,320,000 $ 0.06 The fair value of options granted has been estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions: August 31, 2020 August 31, 2019 Expected volatility 163% N/A Risk-free interest rate 1.16% N/A Expected life 2 years N/A Dividend yield NIL N/A Estimated fair value per option $0.01 N/A The Company has the following options outstanding and exercisable. August 31, 2020 Options outstanding and exercisable Number Remaining Exercise prices of shares contractual life (years) $0.07 550,000 2.73 $0.06 535,000 2.70 $0.05 800,000 2.16 $0.10 500,000 1.67 $0.02 2,000,000 1.49 $0.07 1,500,000 1.42 $0.07 1,535,000 1.39 $0.07 800,000 1.05 $0.05 1,100,000* 0.15 9,320,000 1.48 The aggregate intrinsic value for options outstanding and exercisable as at August 31, 2020 was $Nil. * Expired subsequent to the year ended August 31, 2020. Warrants There were no warrants issued during the year ended August 31, 2020. During the year ended August 31, 2019, the Company issued 7,731,769 warrants attached to units in private placements and 705,100 broker warrants in connection with the private placements. The fair value of the brokers warrants was $12,861, recorded as share issuance costs off-setting the gross proceeds of private placements in additional-paid-in-capital, and was calculated using the Black Scholes option pricing model, with the following weighted average assumptions: expected volatility 150%, risk-free interest rate: 2.38%, expected life: 3.71 years, dividend yield: 0.00%. A summary of changes in warrants is presented below: Warrants Outstanding Weighted Average Number of warrants Exercise Price Balance, August 31, 2018 40,739,060 $ 0.06 Expired (23,034,470 ) 0.07 Issued 8,436,869 0.04 Balance, August 31, 2019 26,141,459 $ 0.06 Expired (12,904,590 ) 0.07 Balance, August 31, 2020 13,236,869 $ 0.05 The Company has the following warrants outstanding and exercisable: Number Exercise Expiry Outstanding 1 Price Date 6,009,369 $ 0.040 March 27, 2023 2,427,500 $ 0.050 September 21, 2021 4,800,000 $ 0.050 August 31, 2021 13,236,869 1

COMMITMENTS

COMMITMENTS	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS [Text Block]	10. COMMITMENTS The Company has a consulting agreement with the President of the Company for corporate administration and consulting services for $3,500 per month plus goods and services tax ("GST") on a continuing basis. The President voluntarily suspended and terminated accrual of these consulting fees commencing on December 1, 2019 and continuing until such time as the Company's financial condition permits a resumption of such cost.	9. COMMITMENTS The Company has a consulting agreement with the President of the Company for corporate administration and consulting services for $3,500 per month plus goods and services tax ("GST") on a continuing basis. The President voluntarily suspended and terminated accrual of these consulting fees commencing on December 1, 2019 and continuing until such time as the Company's financial condition permits a resumption of such cost.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Aug. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES [Text Block]	10. INCOME TAXES The following table reconciles the income tax benefit at the U.S. Federal statutory income tax rates to income tax benefit at the Company's effective tax rates at August 31, 2020 and 2019: August 31, 2020 August 31, 2019 Income (loss) before taxes $ 34,132 $ (422,341 ) Statutory tax rate 21.0% 21.0% Expected income tax expense (recovery) 7,168 (88,692 ) Non-deductible items 3,635 — Change in enacted rates and other 4,441 — Change in valuation allowance (15,244 ) 88,692 Income tax expense (recovery) $ — $ — Deferred taxes reflect the tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes. Deferred tax assets (liabilities) at August 31, 2020 and 2019 are comprised of the following: August 31, 2020 August 31, 2019 Net operating loss carry forwards $ 2,776,534 $ 2,787,648 Marketable securities 583 5,698 Financing costs 2,195 4,725 Intangible assets 4,725 4,725 Mineral property 49,330 45,816 Capital loss carry forwards 4,526 4,526 2,837,893 2,853,138 Valuation allowance 2,837,893 2,853,138 Deferred tax assets (liabilities) $ — $ — The Company has net operating loss carry forwards of approximately $13,220,000 (2019 - 13,275,000) which may be carried forward to 2025 and onwards to apply against future taxable income for US tax purposes, subject to the final determination by the taxation authority, expiring in the following years. Future tax assets have not been recognized because it is not probable that future taxable profit will be available against which the Company can utilize the benefits therefrom.

SEGMENTED INFORMATION

SEGMENTED INFORMATION	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020
Segment Reporting [Abstract]
SEGMENTED INFORMATION [Text Block]	11. SEGMENTED INFORMATION As at February 28, 2021 and August 31, 2020 , the Company is operating its business in one reportable segment: natural resource acquisitions. All of the Company's material long-lived assets are located in the United States.	11. SEGMENTED INFORMATION As at August 31, 2020 and August 31, 2019, the Company is operating its business in one reportable segment: natural resource acquisitions.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS [Text Block]	12. SUBSEQUENT EVENTS During March 2021, the Company issued 200,000 common shares as a result of the exercise of 200,000 stock options exercised at $0.07 per common share.	12. SUBSEQUENT EVENTS On October 29, 2020 the Company signed a 1% royalty agreement with respect to any future commercial lithium production from the Company's Clayton Valley, Nevada claims in exchange for $250,000. The Company has a right of first refusal to repurchase the royalty upon any proposed sale by the royalty holder to a third party.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation [Policy Text Block]	a) Basis of Presentation The accompanying unaudited condensed interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and the instructions to Securities and Exchange Commission ("SEC") Form 10-Q and Article 10 of SEC Regulation S-X. They do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. Therefore, these financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended August 31, 2020.	a. Basis of Presentation The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles.
Mineral Properties [Policy Text Block]		b. Mineral Properties Acquisition costs of mineral rights are initially capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time proven or probable reserves are established for that project. Acquisition costs include cash consideration and the fair market value of shares issued on the acquisition of mineral properties. Expenditures relating to exploration activities are expensed as incurred and expenditures relating to pre-extraction activities are expensed as incurred until such time proven or probable reserves are established for that project, after which subsequent expenditures relating to development activities for that particular project are capitalized as incurred. Where proven and probable reserves have been established, the project's capitalized expenditures are depleted over proven and probable reserves using the units-of production method upon commencement of production. Where proven and probable reserves have not been established, the project's capitalized expenditures are depleted over the estimated extraction life using the straight-line method upon commencement of extraction. The Company has not established proven or probable reserves for any of its projects. The carrying values of the mineral rights are assessed for impairment by management on a quarterly basis and as required whenever indicators of impairment exist. An impairment loss is recognized if it is determined that the carrying value is not recoverable and exceeds fair value.
Stock-Based Compensation [Policy Text Block]		c. Stock-Based Compensation The Company followed Accounting Standards Codification ("ASC") 718, "Compensation - Stock Compensation", to account for its stock options and similar equity instruments issued. Accordingly, compensation costs attributable to stock options or similar equity instruments granted are measured at the fair value at the grant date, and expensed over the expected vesting period. ASC 718 requires excess tax benefits be reported as a financing cash inflow rather than as a reduction of taxes paid.
Accounting Estimates [Policy Text Block]	b) Accounting Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. On an ongoing basis, we evaluate our estimates, judgments, and assumptions, including those related to stock based compensation (expense and liability). Our estimates, judgments, and assumptions are based on historical experience, future expectations, and other factors which we believe to be reasonable. Actual results could differ from those estimates and assumptions.	d. Accounting Estimates The preparation of financial statements in conformity with U.S GAAP requires us to make certain estimates, judgements and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Some of the Company's accounting policies require us to make subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. These accounting policies involve critical accounting estimates because they are particularly dependent on estimates and assumptions made by management about matters that are highly uncertain at the time the accounting estimates are made. Although we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have been used. Changes in the accounting estimates used by the Company are reasonably likely to occur from time to time, which may have a material effect on the presentation of financial condition and results of operations. The Company reviews these estimates, judgments and assumptions periodically and reflect the effects of revisions in the period in which they are deemed to be necessary. We believe that these estimates are reasonable; however, actual results could differ from these estimates. Significant accounting estimates and assumptions are used for, but not limited to: a) Judgement is required in determining whether deferred tax assets are recognized on the balance sheet. The recognition of deferred tax assets requires management to assess the likelihood that the Company will generate taxable income in future periods to utilize the deferred tax assets. Due to the Company's history of losses, deferred tax assets have not been recognized by the Company. b) The Company provides compensation benefits to its employees, directors, officers, and consultants, through a stock option plan. The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model. Expected volatility assumption used in the model is based on the historical volatility of the Company's share price. The Company uses historical data to estimate the period of option exercises for use in the valuation model. The risk-free interest rate for the expected term of the option is based on the yields of government bonds. Changes in these assumptions, especially the share price volatility and the expected life determination could have a material impact on the Company's profit and loss for the periods presented. All estimates used in the model are based on historical data which may not be representative of future results.
Earnings Per Share [Policy Text Blcok]		e. Earnings Per Share Loss per share is computed using the weighted average number of shares outstanding during the period. The Company has adopted ASC 220 "Earnings Per Share". Diluted loss per share is equivalent to basic loss per share because the potential exercise of the equity-based financial instruments was anti-dilutive. Basic earnings per share ("EPS") is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method. Dilutive potential common shares include outstanding stock options and stock awards.
Foreign Currency Translations [Policy Text Block]		f. Foreign Currency Translations The Company's operations are located in the United States of America and has its office in Canada. The Company maintains its accounting records in U.S. Dollars, as follows: At the transaction date, each asset, liability, revenue and expense that was acquired or incurred in a foreign currency is translated into U.S. dollars by the using of the exchange rate in effect at that date. At the year end, monetary assets and liabilities are translated at the exchange rate in effect at that date. The resulting foreign exchange gains and losses are included in operations.
Financial Instruments [Policy Text Block]		g. Financial Instruments ASC 820 "Fair Value Measurements and Disclosures" requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 - Quoted prices in active markets for identical assets or liabilities; Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing. The Company's financial instruments consist primarily of cash, marketable securities, accounts receivable, accounts payable, loan from related party and due to related parties. The carrying amounts of these financial instruments approximate their fair values due to their short maturities. Cash and marketable securities are in level 1 within the fair value hierarchy. The Company's operations are in United States of America and Canada, which results in exposure to market risks from changes in foreign currency rates. The financial risk is the risk to the Company's operations that arise from fluctuations in foreign exchange rates and the degree of volatility of these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk.
Income Taxes [Policy Text Block]		h. Income Taxes The Company has adopted ASC 740, "Income Taxes", which requires the Company to recognize deferred tax liabilities and assets for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns using the liability method. Under this method, deferred tax liabilities and assets are determined based on the temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the year in which the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized.
Long-Lived Assets Impairment [Policy Text Block]		i. Long-Lived Assets Impairment In accordance with ASC 360, "Accounting for Impairment or Disposal of Long Lived Assets", the carrying value of long lived assets are tested for recoverability whenever events or changes in circumstances indicate that its carrying amount may not be recoverable. The Company recognizes impairment when the sum of the expected undiscounted future cash flows is less than the carrying amount of the asset. Impairment losses, if any, are measured as the excess of the carrying amount of the asset over its estimated fair value.
Asset Retirement Obligations [Policy Text Block]		j. Asset Retirement Obligations The Company accounts for asset retirement obligations in accordance with the provisions of ASC 410, "Asset Retirement and Environmental Obligations". ASC 410 requires the Company to record the fair value of an asset retirement obligation as a liability in the period in which it incurs a legal obligation associated with the retirement of tangible long-lived assets that result from the acquisition, construction, development and/or normal use of the assets. The Company does not believe it has any asset retirement obligation as of August 31, 2020 and 2019.
Comprehensive Income [Policy Text Block]		k. Comprehensive Income The Company has adopted ASC 220, "Comprehensive Income", which establishes standards for reporting and display of comprehensive income, its components and accumulated balances. The Company is disclosing this information on its Statement of Stockholders' Deficiency. Comprehensive income comprises equity except those transactions resulting from investments by owners and distributions to owners.
Concentration of credit risk [Policy Text Block]		l. Concentration of credit risk The Company places its cash with high credit quality financial institution.
Commitments and Contingencies [Policy Text Block]		m. Commitments and Contingencies In accordance with ASC 450-20, Accounting for Contingencies, the Company records accruals for such loss contingencies when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. In the event that estimates or assumptions prove to differ from actual results, adjustments are made in subsequent periods to reflect more current information. Historically, the Company has not experienced any material claims.
Research and Development [Policy Text Block]		n. Research and Development Research and development costs are expensed as incurred.
Recently Adopted Accounting Pronouncements [Policy Text Block]		o. Recently adopted Accounting Pronouncements In June 2018, the FASB issued ASU 2018-07, which simplifies the accounting for nonemployee share-based payment transactions. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor's own operations by issuing share-based payment awards. The adoption of this ASU did not have any impact on these financial statements. In February 2016, Topic 842, Leases was issued to replace the leases requirements in Topic 840, Leases. The main difference between previous GAAP and Topic 842 is the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. A lessee should recognize in the balance sheet a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. The adoption of this standard did not have any impact on the Company's results of operations, financial condition, cash flows, and financial statement disclosures, as the Company's leases are all for terms of less than 12 months.
New Accounting Pronouncements [Policy Text Block]		p. New Accounting Pronouncements In June 2016, the FASB issued a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The standard will be adopted upon the effective date for us beginning September 1, 2020. The adoption of the standard is not expected to have a significant impact on the Company's financial statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements to Fair Value Measurement. For all entities, amendments are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. Early adoption is permitted. An entity is permitted to early adopt any removed or modified disclosures upon issuance of ASU No. 2018-13 and delay adoption of the additional disclosures until their effective date. We do not expect that the adoption of this ASU will have a significant impact on our financial statements. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company's financial statements upon adoption.

MARKETABLE SECURITIES (Tables)

MARKETABLE SECURITIES (Tables)	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Schedule of movement in marketable securities [Table Text Block]	Balance, August 31, 2019 — Additions - cost 21,153 Unrealized gain 3,201 Balance, August 31, 2020 24,354 Proceeds from disposals (31,905 ) Gain on disposals 22,504 Unrealized gain 28,247 Balance, February 28, 2021 43,200	Balance, August 31, 2019 — Additions - cost 21,153 Unrealized gain 3,201 Balance, August 31, 2020 24,354

STOCK OPTIONS AND WARRANTS (Tab

STOCK OPTIONS AND WARRANTS (Tables)	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020
Share-based Payment Arrangement [Abstract]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Expected dividend yield 0.00% Expected stock volatility 98% Risk-free interest rate 0.40% Expected life of options (years) 5.00 Expected forfeiture rate 0.00% Grant date fair value per option $0.06	August 31, 2020 August 31, 2019 Expected volatility 163% N/A Risk-free interest rate 1.16% N/A Expected life 2 years N/A Dividend yield NIL N/A Estimated fair value per option $0.01 N/A
Share-based Payment Arrangement, Option, Activity [Table Text Block]	Options Outstanding Weighted Average Number of Shares Exercise Price Balance, August 31, 2019 8,320,000 $ 0.07 Issued 2,000,000 0.02 Expired (1,000,000 ) 0.10 Balance, August 31, 2020 9,320,000 $ 0.06 Issued 5,000,000 0.10 Expired (1,100,000 ) 0.05 Exercised (2,993,224 ) 0.04 Balance, February 28, 2021 10,226,776 $ 0.08	Options Outstanding Weighted Average Number of Shares Exercise Price Balance, August 31, 2018 8,570,000 $ 0.07 Expired (250,000 ) 0.06 Balance, August 31, 2019 8,320,000 $ 0.07 Granted 2,000,000 0.02 Expired (1,000,000 ) 0.10 Balance, August 31, 2020 9,320,000 $ 0.06
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	February 28, 2021 Issue Date Expiry Date Exercise Price Number of Options Remaining Life September 19, 2016 September 19, 2021 0.07 700,000* 0.56 years January 20, 2017 January 20, 2022 0.07 1,200,000* 0.89 years January 31, 2017 January 31, 2022 0.07 1,250,000* 0.92 years May 2, 2017 May 2, 2022 0.10 500,000* 1.17 years October 27, 2017 October 27, 2022 0.05 800,000* 1.66 years May 11, 2018 May 11, 2023 0.06 500,000* 2.20 years May 22, 2018 May 22, 2023 0.07 550,000* 2.23 years February 25, 2020 February 25, 2022 0.02 226,776* 0.99 years December 14, 2020 December 14, 2025 0.05 2,100,000* 4.79 years January 28, 2021 January 28, 2026 0.14 2,000,000* 4.92 years February 4, 2021 February 4, 2026 0.18 100,000 4.94 years February 5, 2021 February 5, 2026 0.18 300,000 4.94 years 0.08 10,226,776 2.52 years *As at February 28, 2021 the market price of the Company's common shares was $0.1426 per share. A total of 9,826,776 incentive stock options were in the money with an intrinsic value of $882,363. August 31, 2020 Issue Date Expiry Date Exercise Price Number of Options Remaining Life October 23, 2015 October 23, 2020 0.05 1,100,000 0.15 years September 19, 2016 September 19, 2021 0.07 800,000 1.05 years January 20, 2017 January 20, 2022 0.07 1,535,000 1.39 years January 31, 2017 January 31, 2022 0.07 1,500,000 1.42 years May 2, 2017 May 2, 2022 0.10 500,000 1.67 years October 27, 2017 October 27, 2022 0.05 800,000 2.16 years May 11, 2018 May 11, 2023 0.06 535,000 2.70 years May 22, 2018 May 22, 2023 0.07 550,000 2.73 years February 25, 2020 February 25, 2022 0.02 2,000,000 1.49 years 0.06 9,320,000 1.48 years	August 31, 2020 Options outstanding and exercisable Number Remaining Exercise prices of shares contractual life (years) $0.07 550,000 2.73 $0.06 535,000 2.70 $0.05 800,000 2.16 $0.10 500,000 1.67 $0.02 2,000,000 1.49 $0.07 1,500,000 1.42 $0.07 1,535,000 1.39 $0.07 800,000 1.05 $0.05 1,100,000* 0.15 9,320,000 1.48
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block]	Weighted Average Number of warrants Exercise Price Balance, August 31, 2019 26,141,459 $ 0.06 Expired (12,904,590 ) 0.07 Balance, August 31, 2020 13,236,869 $ 0.06 Issued 1,500,000 0.09 Exercised (40,000 ) 0.04 Balance, February 28, 2021 14,696,869 $ 0.05	Warrants Outstanding Weighted Average Number of warrants Exercise Price Balance, August 31, 2018 40,739,060 $ 0.06 Expired (23,034,470 ) 0.07 Issued 8,436,869 0.04 Balance, August 31, 2019 26,141,459 $ 0.06 Expired (12,904,590 ) 0.07 Balance, August 31, 2020 13,236,869 $ 0.05
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	The Company has the following warrants outstanding: February 28, 2021 Issue Date Expiry Date Exercise Price Number of Warrants* August 31, 2018 August 31, 2021 0.05 4,800,000 September 21, 2018 September 21, 2021 0.05 2,427,500 March 27, 2019 March 27, 2023 0.04 5,969,369 January 14, 2021 January 14, 2022 0.09 1,500,000 0.05 14,696,869 *Each warrant entitles a holder to purchase one common share. August 31, 2020 Issue Date Expiry Date Exercise Price Number of Warrants* August 31, 2018 August 31, 2021 0.05 4,800,000 September 21, 2018 September 21, 2021 0.05 2,427,500 March 27, 2019 March 27, 2023 0.04 6,009,369 0.05 13,236,869	Number Exercise Expiry Outstanding 1 Price Date 6,009,369 $ 0.040 March 27, 2023 2,427,500 $ 0.050 September 21, 2021 4,800,000 $ 0.050 August 31, 2021 13,236,869 1

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Aug. 31, 2020
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	August 31, 2020 August 31, 2019 Income (loss) before taxes $ 34,132 $ (422,341 ) Statutory tax rate 21.0% 21.0% Expected income tax expense (recovery) 7,168 (88,692 ) Non-deductible items 3,635 — Change in enacted rates and other 4,441 — Change in valuation allowance (15,244 ) 88,692 Income tax expense (recovery) $ — $ —
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	August 31, 2020 August 31, 2019 Net operating loss carry forwards $ 2,776,534 $ 2,787,648 Marketable securities 583 5,698 Financing costs 2,195 4,725 Intangible assets 4,725 4,725 Mineral property 49,330 45,816 Capital loss carry forwards 4,526 4,526 2,837,893 2,853,138 Valuation allowance 2,837,893 2,853,138 Deferred tax assets (liabilities) $ — $ —

GOING CONCERN UNCERTAINTY (Narr

GOING CONCERN UNCERTAINTY (Narrative) (Details) - USD ($)	6 Months Ended		12 Months Ended
	Feb. 28, 2021	Feb. 29, 2020	Aug. 31, 2020	Aug. 31, 2019
Going Concern Uncertainty [Abstract]
Net cash (used in) operating activities	$ (167,835)	$ (61,713)	$ (127,109)	$ (325,988)
Working Capital Deficit			(392,956)	(455,885)
Cumulative Losses	$ (14,352,649)		$ (14,280,027)	$ (14,314,159)

MARKETABLE SECURITIES (Narrativ

MARKETABLE SECURITIES (Narrative) (Details)	12 Months Ended
	Aug. 31, 2020USD ($)
Marketable Securities [Line Items]
Purchase of marketable securities	$ 21,153
Grayscale Bitcoin Trust [Member]
Marketable Securities [Line Items]
Purchase of marketable securities	$ 21,153

MINERAL PROPERTY (Narrative) (D

MINERAL PROPERTY (Narrative) (Details) - USD ($)	Feb. 11, 2020	Oct. 29, 2020	Oct. 28, 2019	Nov. 30, 2019	Feb. 28, 2021	Aug. 31, 2020
Mineral Industries [Line Items]
Percentage of Land Rights Interest					100.00%	100.00%
Value of shares issued for LOI				$ 11,489		$ 11,489
Eagle Plains Resources Ltd [Member]
Mineral Industries [Line Items]
Percentage of letter of intent			75.00%
Shares issued for LOI			1,000,000
Value of shares issued for LOI			$ 11,489
Clayton Valley [Member]
Mineral Industries [Line Items]
Percentage of royalty agreement	1.00%	1.00%
Total cash consideration	$ 200,000	$ 250,000

PATENTS (Narrative) (Details)

PATENTS (Narrative) (Details)	Dec. 14, 2020USD ($)shares	Feb. 28, 2021USD ($)	Dec. 14, 2020$ / shares
Patent And Trademark [Line Items]
Shares issued for patent | $		$ 69,000
Patents [Member]
Patent And Trademark [Line Items]
Percentage of interest in patent rights acquired			100.00%
Shares issued for patent (Shares) | shares	1,000,000
Number of additional common shares issued in escrow | shares	1,000,000
Shares issued, price per share | $ / shares			$ 0.0345
Shares issued for patent | $	$ 69,000

RELATED PARTY TRANSACTIONS (Nar

RELATED PARTY TRANSACTIONS (Narrative) (Details)	Feb. 05, 2021shares	Feb. 04, 2021shares	Dec. 14, 2020USD ($)shares	Nov. 12, 2020shares	Jan. 28, 2021shares	Feb. 25, 2020shares	Feb. 28, 2021USD ($)	Nov. 30, 2020USD ($)	Feb. 29, 2020USD ($)	Feb. 28, 2021USD ($)shares	Feb. 29, 2020USD ($)	Aug. 31, 2020CAD ($)shares	Aug. 31, 2020USD ($)shares	Aug. 31, 2019USD ($)
Related Party Transaction [Line Items]
Repayment of loan from related party											$ 15,968		$ 15,968
Due to the President							$ 159,959			$ 159,959			$ 188,834	$ 203,221
Stock options granted (shares) | shares	300,000	100,000	2,100,000	500,000	2,000,000	2,000,000				5,000,000		2,000,000	2,000,000
Value of stock options granted							273,236	$ 15,450	$ 17,308
President [Member]
Related Party Transaction [Line Items]
Consulting fees											$ 10,500		$ 10,500	42,000
Repayment of loan from related party										28,875		$ 21,156	15,968
Due to the President							$ 159,959			$ 159,959			188,834	203,221
Stock options granted (shares) | shares			500,000
Value of stock options granted			$ 10,917
Director [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Expenses from Transactions with Related Party													$ 0	$ 395

COMMON STOCK (Narrative) (Detai

COMMON STOCK (Narrative) (Details)	Jan. 14, 2021$ / shares	Jan. 14, 2021USD ($)shares	Dec. 14, 2020shares	Oct. 28, 2019shares	Mar. 27, 2019CAD ($)$ / sharesshares	Mar. 27, 2019USD ($)$ / sharesshares	Sep. 21, 2018CAD ($)$ / sharesshares	Sep. 21, 2018USD ($)$ / sharesshares	Feb. 28, 2021shares	Feb. 28, 2021$ / sharesshares	Aug. 31, 2019$ / sharesshares	Aug. 31, 2020shares	Aug. 31, 2018shares
Stockholders Equity Note [Line Items]
Number of units issued in final tranche of private placement		3,000,000
Units issue price at date of issuance | $ / shares	$ 0.06
Gross proceeds from issuance of units in final tranche of private placement | $		$ 180,000
Description of units issuance in private placement		Each unit consists of one common share of the Company and one half (0.5) of a non-transferable share purchase warrant, each warrant entitling the holder to purchase one additional common share of the Company for a period of 12 months from the date of issuance at a purchase price of $0.09.
Number of common shares issued in exercise of options									2,720,000	2,720,000
Number of common shares issued in exercise of warrants										40,000
Units Issued During Period, Units					5,506,769	5,506,769	2,225,000	2,225,000
Units Issued During Period, Per Unit Amount | $ / shares					$ 0.03		$ 0.03
Units Issued During Period, Value					$ 143,176	$ 106,809	$ 66,750	$ 51,678
Class of Warrant or Right, Grants in Period, Contractual Term					48 months	48 months	36 months	36 months
Class of Warrant or Right, Grants in Period, Net of Forfeitures					502,600	502,600	202,500	202,500		1,500,000	8,436,869
Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price | $ / shares						$ 0.04		$ 0.05		$ 0.09	$ 0.04
Payments of Stock Issuance Costs					$ 13,068	$ 9,748	$ 6,075	$ 4,703
Common Stock, Shares, Issued									136,231,700	136,231,700	127,471,700	128,471,700	127,471,700
Common Stock, Shares, Outstanding									136,231,700	136,231,700	127,471,700	128,471,700
Eagle Plains Resources Ltd [Member]
Stockholders Equity Note [Line Items]
Number of shares issued				1,000,000
Definitive agreement [Member]
Stockholders Equity Note [Line Items]
Number of shares issued			1,000,000
Additional common shares in escrow			1,000,000

STOCK OPTIONS AND WARRANTS (Nar

STOCK OPTIONS AND WARRANTS (Narrative) (Details)	Feb. 05, 2021$ / sharesshares	Feb. 04, 2021$ / sharesshares	Dec. 14, 2020$ / sharesshares	Nov. 12, 2020$ / sharesshares	Jan. 28, 2021$ / sharesshares	Feb. 25, 2020$ / sharesshares	Mar. 27, 2019shares	Sep. 21, 2018shares	Feb. 28, 2021USD ($)shares	Feb. 29, 2020USD ($)	Feb. 28, 2021USD ($)$ / sharesshares	Feb. 29, 2020USD ($)shares	Aug. 31, 2020USD ($)$ / sharesshares	Aug. 31, 2019USD ($)shares	Feb. 28, 2021$ / shares	Feb. 28, 2021USD ($)shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted (shares)	300,000	100,000	2,100,000	500,000	2,000,000	2,000,000					5,000,000		2,000,000
Stock options granted exercise price | $ / shares	$ 0.18	$ 0.18	$ 0.05	$ 0.05	$ 0.14	$ 0.02					$ 0.10		$ 0.02
Stock based compensation | $									$ 273,236	$ 17,308	$ 288,686	$ 17,308	$ 17,308
Stock options exercised (shares)									2,720,000		2,720,000
Proceeds from stock option exercised | $											$ 75,048
Stock options expired											1,100,000	1,000,000	1,000,000	250,000
Market price of common shares | $ / shares															$ 0.1426
Number of incentive stock options in the money																9,826,776
Intrinsic value of stock options | $																$ 882,363
Number of warrants issued							502,600	202,500			1,500,000			8,436,869
Warrants attached to units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of warrants issued														7,731,769
Brokers warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of warrants issued														705,100
Warrants Issued During Period, Value | $														$ 12,861
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate														150.00%
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate														2.38%
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Term														3 years 8 months 15 days
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate														0.00%

COMMITMENTS (Narrative) (Detail

COMMITMENTS (Narrative) (Details) - USD ($)	Feb. 28, 2021	Aug. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Corporate administration and consulting services per month plus goods and services tax	$ 3,500	$ 3,500

INCOME TAXES (Narrative) (Detai

INCOME TAXES (Narrative) (Details) - USD ($)	Aug. 31, 2020	Aug. 31, 2019
Income Tax Disclosure [Abstract]
Net operating loss carry forwards	$ 13,220,000	$ 13,275,000

SUBSEQUENT EVENTS (Narrative) (

SUBSEQUENT EVENTS (Narrative) (Details)	Feb. 11, 2020USD ($)	Mar. 31, 2021$ / sharesshares	Oct. 29, 2020USD ($)	Oct. 29, 2020USD ($)	Feb. 28, 2021shares	Feb. 28, 2021$ / sharesshares
Subsequent Event [Line Items]
Stock options exercised (shares) | shares					2,720,000	2,720,000
Exercise price of stock options exercised | $ / shares						$ 0.04
Clayton Valley [Member]
Subsequent Event [Line Items]
Percentage of royalty agreement	1.00%		1.00%
Total cash consideration | $	$ 200,000		$ 250,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Stock options exercised (shares) | shares		200,000
Exercise price of stock options exercised | $ / shares		$ 0.07
Subsequent Event [Member] | Clayton Valley [Member]
Subsequent Event [Line Items]
Percentage of royalty agreement				1.00%
Total cash consideration | $				$ 250,000

MARKETABLE SECURITIES - Schedul

MARKETABLE SECURITIES - Schedule of movement in marketable securities (Details) - USD ($)	3 Months Ended	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Feb. 28, 2021	Aug. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Beginning Balance		$ 24,354	$ 0
Additions - cost			21,153
Proceeds from disposals		(31,905)
Gain on disposals	$ 21,610	22,504
Unrealized gain	11,997	28,247	3,201
Ending Balance	$ 43,200	$ 43,200	$ 24,354

STOCK OPTIONS AND WARRANTS - Sc

STOCK OPTIONS AND WARRANTS - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)	6 Months Ended	12 Months Ended
	Feb. 28, 2021$ / shares	Aug. 31, 2020USD ($)
Share-based Payment Arrangement [Abstract]
Expected dividend yield	0.00%
Expected stock volatility	98.00%	163.00%
Risk-free interest rate	0.40%	1.16%
Expected life of options (years)	5 years	2 years
Expected forfeiture rate	0.00%
Grant date fair value per option | $ / shares	$ 0.06
Estimated fair value per option | $		$ 0.01

STOCK OPTIONS AND WARRANTS - _2

STOCK OPTIONS AND WARRANTS - Schedule of Share-based Compensation, Stock Options, Activity (Details) - $ / shares	Feb. 05, 2021	Feb. 04, 2021	Dec. 14, 2020	Nov. 12, 2020	Jan. 28, 2021	Feb. 25, 2020	Feb. 28, 2021	Feb. 29, 2020	Aug. 31, 2020	Aug. 31, 2019
Share-based Payment Arrangement [Abstract]
Number of options, beginning of period							9,320,000	8,320,000	8,320,000	8,570,000
Options outstanding, weighted average exercise price, beginning of period							$ 0.06	$ 0.07	$ 0.07	$ 0.07
Number of options, issued	300,000	100,000	2,100,000	500,000	2,000,000	2,000,000	5,000,000		2,000,000
Weighted average exercise price of options issued	$ 0.18	$ 0.18	$ 0.05	$ 0.05	$ 0.14	$ 0.02	$ 0.10		$ 0.02
Number of options, expired							(1,100,000)	(1,000,000)	(1,000,000)	(250,000)
Weighted average exercise price of options expired							$ 0.05		$ 0.10	$ 0.06
Number of options, exercised							(2,993,224)
Weighted average exercise price of options exercised							$ 0.04
Number of options, end of period							10,226,776		9,320,000	8,320,000
Options outstanding, weighted average exercise price, end of period							$ 0.08		$ 0.06	$ 0.07

STOCK OPTIONS AND WARRANTS - Di

STOCK OPTIONS AND WARRANTS - Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) - $ / shares	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020	Aug. 31, 2019	Aug. 31, 2018
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise prices	$ 0.08	$ 0.06	$ 0.07	$ 0.07
Options outstanding and exercisable Number of shares	10,226,776	9,320,000	8,320,000	8,570,000
Options outstanding and exercisable Remaining contractual life	2 years 6 months 7 days	1 year 5 months 23 days
Option exercise price 1 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise prices		$ 0.07
Options outstanding and exercisable Number of shares		550,000
Options outstanding and exercisable Remaining contractual life		2 years 8 months 23 days
Option exercise price 2 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise prices		$ 0.06
Options outstanding and exercisable Number of shares		535,000
Options outstanding and exercisable Remaining contractual life		2 years 8 months 12 days
Option exercise price 3 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise prices		$ 0.05
Options outstanding and exercisable Number of shares		800,000
Options outstanding and exercisable Remaining contractual life		2 years 1 month 28 days
Option exercise price 4 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise prices		$ 0.10
Options outstanding and exercisable Number of shares		500,000
Options outstanding and exercisable Remaining contractual life		1 year 8 months 1 day
Option exercise price 5 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise prices		$ 0.02
Options outstanding and exercisable Number of shares		2,000,000
Options outstanding and exercisable Remaining contractual life		1 year 5 months 26 days
Option exercise price 6 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise prices		$ 0.07
Options outstanding and exercisable Number of shares		1,500,000
Options outstanding and exercisable Remaining contractual life		1 year 5 months 1 day
Option exercise price 7 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise prices		$ 0.07
Options outstanding and exercisable Number of shares		1,535,000
Options outstanding and exercisable Remaining contractual life		1 year 4 months 20 days
Option exercise price 8 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise prices		$ 0.07
Options outstanding and exercisable Number of shares		800,000
Options outstanding and exercisable Remaining contractual life		1 year 18 days
Option exercise price 9 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise prices		$ 0.05
Options outstanding and exercisable Number of shares		1,100,000
Options outstanding and exercisable Remaining contractual life		1 month 24 days
October 23, 2015 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Issue Date		Oct. 23, 2015
Expiry Date		Oct. 23, 2020
Exercise prices		$ 0.05
Options outstanding and exercisable Number of shares		1,100,000
Options outstanding and exercisable Remaining contractual life		1 month 24 days
September 19, 2016 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Issue Date	Sep. 19, 2016	Sep. 19, 2016
Expiry Date	Sep. 19, 2021	Sep. 19, 2021
Exercise prices	$ 0.07	$ 0.07
Options outstanding and exercisable Number of shares	700,000	800,000
Options outstanding and exercisable Remaining contractual life	6 months 21 days	1 year 18 days
January 20, 2017 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Issue Date	Jan. 20, 2017	Jan. 20, 2017
Expiry Date	Jan. 20, 2022	Jan. 20, 2022
Exercise prices	$ 0.07	$ 0.07
Options outstanding and exercisable Number of shares	1,200,000	1,535,000
Options outstanding and exercisable Remaining contractual life	10 months 20 days	1 year 4 months 20 days
January 31, 2017 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Issue Date	Jan. 31, 2017	Jan. 31, 2017
Expiry Date	Jan. 31, 2022	Jan. 31, 2022
Exercise prices	$ 0.07	$ 0.07
Options outstanding and exercisable Number of shares	1,250,000	1,500,000
Options outstanding and exercisable Remaining contractual life	11 months 1 day	1 year 5 months 1 day
May 2, 2017 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Issue Date	May 2, 2017	May 2, 2017
Expiry Date	May 2, 2022	May 2, 2022
Exercise prices	$ 0.10	$ 0.10
Options outstanding and exercisable Number of shares	500,000	500,000
Options outstanding and exercisable Remaining contractual life	1 year 2 months 1 day	1 year 8 months 1 day
October 27, 2017 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Issue Date	Oct. 27, 2017	Oct. 27, 2017
Expiry Date	Oct. 27, 2022	Oct. 27, 2022
Exercise prices	$ 0.05	$ 0.05
Options outstanding and exercisable Number of shares	800,000	800,000
Options outstanding and exercisable Remaining contractual life	1 year 7 months 28 days	2 years 1 month 28 days
May 11, 2018 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Issue Date	May 11, 2018	May 11, 2018
Expiry Date	May 11, 2023	May 11, 2023
Exercise prices	$ 0.06	$ 0.06
Options outstanding and exercisable Number of shares	500,000	535,000
Options outstanding and exercisable Remaining contractual life	2 years 2 months 12 days	2 years 8 months 12 days
May 22, 2018 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Issue Date	May 22, 2018	May 22, 2018
Expiry Date	May 22, 2023	May 22, 2023
Exercise prices	$ 0.07	$ 0.07
Options outstanding and exercisable Number of shares	550,000	550,000
Options outstanding and exercisable Remaining contractual life	2 years 2 months 23 days	2 years 8 months 23 days
February 25, 2020 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Issue Date	Feb. 25, 2020	Feb. 25, 2020
Expiry Date	Feb. 25, 2022	Feb. 25, 2022
Exercise prices	$ 0.02	$ 0.02
Options outstanding and exercisable Number of shares	226,776	2,000,000
Options outstanding and exercisable Remaining contractual life	11 months 26 days	1 year 5 months 26 days
December 14, 2020 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Issue Date	Dec. 14, 2020
Expiry Date	Dec. 14, 2025
Exercise prices	$ 0.05
Options outstanding and exercisable Number of shares	2,100,000
Options outstanding and exercisable Remaining contractual life	4 years 9 months 14 days
January 28, 2021 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Issue Date	Jan. 28, 2021
Expiry Date	Jan. 28, 2026
Exercise prices	$ 0.14
Options outstanding and exercisable Number of shares	2,000,000
Options outstanding and exercisable Remaining contractual life	4 years 11 months 1 day
February 4, 2021 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Issue Date	Feb. 4, 2021
Expiry Date	Feb. 4, 2026
Exercise prices	$ 0.18
Options outstanding and exercisable Number of shares	100,000
Options outstanding and exercisable Remaining contractual life	4 years 11 months 8 days
February 5, 2021 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Issue Date	Feb. 5, 2021
Expiry Date	Feb. 5, 2026
Exercise prices	$ 0.18
Options outstanding and exercisable Number of shares	300,000
Options outstanding and exercisable Remaining contractual life	4 years 11 months 8 days

STOCK OPTIONS AND WARRANTS - _3

STOCK OPTIONS AND WARRANTS - Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details) - $ / shares	1 Months Ended		6 Months Ended	12 Months Ended
	Mar. 27, 2019	Sep. 21, 2018	Feb. 28, 2021	Aug. 31, 2020	Aug. 31, 2019
Share-based Payment Arrangement [Abstract]
Class of Warrant or Right, Outstanding, Beginning of Period			13,236,869	26,141,459	40,739,060
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price, Beginning of Period			$ 0.06	$ 0.06	$ 0.06
Class of Warrant or Right, Expirations in Period				(12,904,590)	(23,034,470)
Class of Warrant or Right, Expirations in Period, Weighted Average Exercise Price				$ 0.07	$ 0.07
Class of Warrant or Right, Grants in Period, Net of Forfeitures	502,600	202,500	1,500,000		8,436,869
Class of Warrant or Right, Grants in Period, Weighted Average Exercise Price	$ 0.04	$ 0.05	$ 0.09		$ 0.04
Class of Warrant or Right, Exercises in Period			(40,000)
Class of Warrant or Right, Exercises in Period, Weighted Average Exercise Price			$ 0.04
Class of Warrant or Right, Outstanding, End of Period			14,696,869	13,236,869	26,141,459
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price, End of Period			$ 0.05	$ 0.06	$ 0.06

STOCK OPTIONS AND WARRANTS - _4

STOCK OPTIONS AND WARRANTS - Schedule of Stockholders' Equity Note, Warrants or Rights (Details) - $ / shares	6 Months Ended	12 Months Ended
	Feb. 28, 2021	Aug. 31, 2020	Aug. 31, 2019	Aug. 31, 2018
Class of Warrant or Right [Line Items]
Number Outstanding	14,696,869	13,236,869	26,141,459	40,739,060
Exercise Price	$ 0.05
August 31, 2018 [Member]
Class of Warrant or Right [Line Items]
Issue Date	Aug. 31, 2018	Aug. 31, 2018
Expiry Date	Aug. 31, 2021	Aug. 31, 2021
Number Outstanding	4,800,000	4,800,000
Exercise Price	$ 0.05	$ 0.05
September 21, 2018 [Member]
Class of Warrant or Right [Line Items]
Issue Date	Sep. 21, 2018	Sep. 21, 2018
Expiry Date	Sep. 21, 2021	Sep. 21, 2021
Number Outstanding	2,427,500	2,427,500
Exercise Price	$ 0.05	$ 0.05
March 27, 2019 [Member]
Class of Warrant or Right [Line Items]
Issue Date	Mar. 27, 2019	Mar. 27, 2019
Expiry Date	Mar. 27, 2023	Mar. 27, 2023
Number Outstanding	5,969,369	6,009,369
Exercise Price	$ 0.04	$ 0.04
January 14, 2021 [Member]
Class of Warrant or Right [Line Items]
Issue Date	Jan. 14, 2021
Expiry Date	Jan. 14, 2022
Number Outstanding	1,500,000
Exercise Price	$ 0.09
Warrant exercise price 1 [Member]
Class of Warrant or Right [Line Items]
Number Outstanding		6,009,369
Exercise Price		$ 0.040
Warrant exercise price 2 [Member]
Class of Warrant or Right [Line Items]
Number Outstanding		2,427,500
Exercise Price		$ 0.050
Warrant exercise price 3 [Member]
Class of Warrant or Right [Line Items]
Number Outstanding		4,800,000
Exercise Price		$ 0.050

INCOME TAXES - Schedule of Effe

INCOME TAXES - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)	12 Months Ended
	Aug. 31, 2020	Aug. 31, 2019
Income Tax Disclosure [Abstract]
Income (loss) before taxes	$ 34,132	$ (422,341)
Statutory tax rate	21.00%	21.00%
Expected income tax expense (recovery)	$ 7,168	$ (88,692)
Non-deductible items	3,635	0
Change in enacted rates and other	4,441	0
Change in valuation allowance	(15,244)	88,692
Income tax expense (recovery)	$ 0	$ 0

INCOME TAXES - Schedule of Defe

INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Aug. 31, 2020	Aug. 31, 2019
Deferred Tax Assets Liability [Line Items]
Net operating loss carry forwards	$ 2,776,534	$ 2,787,648
Capital loss carry forwards	4,526	4,526
Deferred tax assets, gross	2,837,893	2,853,138
Valuation allowance	2,837,893	2,853,138
Deferred tax assets (liabilities)	0	0
Marketable securities [Member]
Deferred Tax Assets Liability [Line Items]
Deferred tax assets, other	583	5,698
Financing costs [Member]
Deferred Tax Assets Liability [Line Items]
Deferred tax assets, other	2,195	4,725
Intangible Assets [Member]
Deferred Tax Assets Liability [Line Items]
Deferred tax assets, other	4,725	4,725
Mineral property [Member]
Deferred Tax Assets Liability [Line Items]
Deferred tax assets, other	$ 49,330	$ 45,816